Researchers from Violet Therapeutics Inc. presented the discovery of VTT-001, a novel EPHB3 inhibitor designed to target astrocyte-mediated disease mechanisms. EPHB3 is a receptor tyrosine kinase ...

eInstitute for Surgical Pathology, Medical Center and Faculty of Medicine, ALU, Germany fDepartment of Hematology and Oncology, University Medical Center, ALU, Freiburg, Germany ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The fidelity of signal transduction requires ...

Background— Ephrin-B2, one of the transmembrane ligands, is a genetic marker of arterial endothelial cells (ECs) at embryonic stages and is essential for cardiovascular development, but its roles in ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The plant homeodomain zinc-finger protein, ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...

Eph receptor tyrosine kinases participate in a variety of normal and pathogenic processes during development and throughout adulthood. This versatility is likely facilitated by the ability of Eph ...

2049 EPHB3 EPH receptor B3 0 1 2101 ESRRA estrogen related receptor alpha 0 1 8717 TRADD TNFRSF1A-associated via death domain 0 1 10594 PRPF8 pre-mRNA processing factor 8 0 1 826 CAPNS1 calpain, small ...

As scientists race to discover new and effective antiviral drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many novel approaches are being utilized. Now, a new study ...